In vivo evaluation of the uptake of [123I]FIAU, [123I]IVFRU and [123I]IVFAU by normal mouse brain:: Potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas

被引:5
|
作者
Li, H. -F. [1 ]
Winkeler, A. [1 ,2 ,3 ]
Moharram, S. [4 ]
Knaus, E. E. [4 ]
Dittmar, K. [1 ,2 ,3 ]
Stoeckle, M. [1 ]
Heiss, W. D. [2 ,3 ]
Wiebe, L. I. [4 ]
Jacob, A. J. [2 ,3 ]
机构
[1] Univ Cologne, MPI Neurol Res, Dept Neurol, PET Lab, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Cologne, Germany
[3] Univ Cologne, Ctr Mol Med, Cologne, Germany
[4] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
来源
关键词
blood-brain barrier (BBB); gene expression; brain permeability; herpes simplex virus type 1 thymidine kinase (HSV-1-TK);
D O I
10.1080/15257770701571933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Radioiodinated 5-iodo-1-(2-fluoro-2-deoxy--D-arabinofuranosyl)uracil (F *IAU) is most commonly used for noninvasive assessment of herpes simplex virus type 1 thymidine kinase (HSV-1-tk) gene expression. However, it does not permeate the intact blood-brain barrier (BBB) because of its moderate lipophilicity. In this work, three iodo-nucleosides, FIAU, IVFRU, and IVFAU, were radiolabeled with iodine-123 and tested for permeation of the BBB in mice and for potential measurement of HSV-1-tk gene expression in gliomas. The results demonstrate that brain uptake and retention of these nucleosides is not directly related to their lipophilicity. The low brain uptake of IVFAU, in conjunction with its higher and constant brain/blood ratio, may reflect greater stability against hydrolysis of the N-glycosidic bond. In vivo PET evaluations of [124I]IVFRU and [124I]IVFAU in tumor-bearing mice are warranted.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 50 条
  • [31] Radiosynthesis, In Vivo Biological Evaluation, and Imaging of Brain Lesions with [123I]-CLINME, a New SPECT Tracer for the Translocator Protein
    Mattner, F.
    Quinlivan, M.
    Greguric, I.
    Pham, T.
    Liu, X.
    Jackson, T.
    Berghofer, P.
    Fookes, C. J. R.
    Dikic, B.
    Gregoire, M. -C.
    Dolle, F.
    Katsifis, A.
    [J]. DISEASE MARKERS, 2015, 2015 : 1 - 11
  • [32] Evaluation of a Novel Adenosine 2a Receptor Imaging in Primate Brain with [123I] MNI 420
    Zhang, X.
    Alagille, D.
    Koren, A. O.
    Batis, J.
    Cosgrove, K.
    Marek, K.
    Seibyl, J. P.
    Tamagnan, G. D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S399 - S399
  • [33] Correlation between postoperative 3-[123I]iodo-L-α-methyltyrosine uptake and survival in patients with gliomas
    Weber, WA
    Dick, S
    Reidl, G
    Dzewas, B
    Busch, R
    Feldmann, HJ
    Molls, M
    Lumenta, CB
    Schwaiger, M
    Grosu, AL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (08) : 1144 - 1150
  • [34] Normal and Abnormal Adrenal glands' Standard Uptake Values in 123I mIBG scintigraphy for diagnosis of Pheochromocytoma and Paraganglioma
    Gregory, R.
    Nowosinska, E.
    Bouchareb, Y.
    Burniston, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S124 - S125
  • [35] In vivo evaluation in rodents of [123I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT2A receptor
    Blanckaert, Peter B. M.
    Burvenich, Ingrid
    Wyffels, Leonie
    De Bruyne, Sylvie
    Moerman, Lieselotte
    De Vos, Filip
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (08) : 861 - 867
  • [36] In vivo assessment of [123I]MNI420, an adenosine 2a SPECT radioligand, in nonhuman primates
    Batis, Jeffery
    Barret, Olivier
    Alagille, David
    Vala, Christine
    Kudej, Greg
    Lee, Hsiaoju
    Marek, Ken
    Seibyl, John
    Tamagnan, Gilles
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S111 - S111
  • [37] A BORON-BASED SYTHESIS OF [123I]IODOSTYRYLBENZOXAZOLE, A POTENTIAL SPECT AGENT FOR IMAGING AMYLOID PLAQUES IN THE BRAIN
    Mereddy, A. R.
    Kabalka, G. W.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S301 - S301
  • [38] Pharmacological evaluation of (S)-8-[123I]iodobretazenil:: a radioligand for in vivo studies of central benzodiazepine receptors
    Katsifis, A
    Mardon, K
    Mattner, F
    Loc'h, C
    McPhee, ME
    Dikic, B
    Kassiou, M
    Ridley, DD
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (02) : 191 - 198
  • [39] In vivo evaluation of Axumin analogs syn- and anti-[123I] IVACBC as potential SPECT tumor imaging agents
    Yu, Weiping
    Goodman, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [40] A Rare Case of Abnormal Diffuse Brain Uptake on an 123I MIBG Scan in a Patient With High-Risk Neuroblastoma
    Basavalingu, Deepashri
    Sadic, Murat
    Cheeney, Safia
    Parisi, Marguerite T.
    [J]. CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 438 - 441